In turn, we demonstrated this by screening a library of 1018 Food and Drug Administration (FDA)-approved drugs in BC cells to search for molecules that modify ERα content and prevent BC cell growth [14,59,61,62]. This evidence concerns the gene ESR1 and breast cancer.